Top of page

Experience

To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.

Filters

Legend Biotech $487 million IPO

Davis Polk advised the underwriters in connection with the $487 million SEC-registered initial public offering by Legend Biotech Corporation of 21,188,750 American Depositary Shares, each…

Sands China $1.5 billion notes offering

Davis Polk advised the joint book-running managers in connection with a Rule 144A/Regulation S notes offering by Sands China Ltd. of $800 million of its 3.800% senior notes due 2026…

Beijing Hongkun $55 million high-yield notes offering

Davis Polk advised Hongkong Ideal Investment Limited Beijing (the “Issuer”) on its $55 million Regulation S offering of 14.750% guaranteed senior notes due 2022, to be consolidated and form…
Back to top